Clinical Insights into the
Diagnosis & Treatment of Epilepsy
A continuing medical education activity sponsored by NAMCP and AAMCN.
This activity is an archive from the
live session at the 2017 Fall Forum. If you participated in
the live session, you are not eligible for continuing education
credits from this archive.
This activity is valid from January 10, 2018 to January 31, 2019
Instructions for CME/CNE: Complete the pre-test, listen to the audio
and view the slides, complete the post test, complete the evaluation
form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your
internet browser without completing the post test, you will have ONE
more opportunity to complete. A score of 70% must be achieved on the
post test to receive continuing education credits. If you do not
pass the post test after two attempts, you will not be eligible to
try again. Once you complete the evaluation form and score 70% or
higher on your post test, you will automatically be given your
To print or save your certificate, you will need to click on the
“download” button and either print or save.
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This presentation is supported by
educational grants from
Lundbeck and UCB, Inc.
Epilepsy is a chronic neurological disorder that affects about 3
million people in the United States and accounts for about $15
billion in medical costs. Diagnosis of epilepsy is made by analyzing
the patient's clinical history as well as performing
neurophysiological and neuroimaging tests. Treatment of epilepsy
involves reducing the number of seizures by administering various
antiepileptic drugs (AEDs), to include anticonvulsants, with the
goal to achieve a seizure-free status. However long-term adherence
is required from patients and unfortunately, more than one-third of
patients continue to experience seizures or suffer from severe
adverse effects. The development of new AEDs continues to increase
and drug therapies can now be individualized to the patient’s
symptoms and needs. It is also important to understand the
mechanisms of action and the pharmacokinetics of antiepileptic drugs
so that these agents can be used effectively in clinical practice,
especially in the combined therapeutic strategies.
Upon Completion of this
activity, participants will be able to:
Know the common types of seizures
and what is needed for an initial medical evaluation for
diagnosis and finding the cause
Understand the process of selection
of antiepileptic drugs based on seizure type and patient
Know indications for referral to a
neurologist and to a specialized epilepsy seizure
Discuss options for
therapy-resistant patients, including drugs, surgery, and
||R. Edward Faught, MD
Professor of Neurology, Emory University
Director, Emory Epilepsy Program
serves on an advisory board for Sage, acts as a
consultant to Biogen and Eisai, and receives research
support from Brain Sentinel and UCB Pharma. His
presentation has been peer reviewed for any bias.
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is
accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
NAMCP designates this enduring material for a maximum of 1 AMA PRA
Category I creditsTM.
The American Association of Managed Care Nurses is accredited as a
provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission
Nurses who complete this activity and achieve a passing score will
receive 1 hour in continuing
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
supported by educational grants from
Lundbeck and UCB, Inc.
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue